Scientists are concerned that a highly contagious new COVID-19 strain Lambda Variant devastating Peru might be immune to vaccinations. The C.37 strain, known as the Lambda variant, was first found in Peru in December 2020, accounting for fewer than 1% of all new cases.
According to a study published in the Financial Times, Lambda Variant currently accounts for approximately 80% of new infections in Peru and has spread to about 27 nations in the last month.
A study at the University of Chile, Santiago, looked at the effects of Lambda Variant on workers receiving two doses of the CoronaVac vaccine in China. Results suggest Lambda is more infectious than Gamma and Alpha and is better able to escape the antibodies produced by vaccines.
According to the World Health Organization, the strain undergoes a number of changes that can result in greater transmission or resistance to neutralizing antibodies. The spike protein used by Lambda to infect human cells has a unique pattern of seven mutations.
According to the data, about 10% of those who are infected die, with a death rate of nearly 600 for every 100,000 citizens, almost double that of the next country, Hungary.
For daily news updates related to finance, business and sports keep following our portal Daily News Capsule
Nikita Dhyani is a passionate writer. She basically writes on Health, Finance, and Politics related topics. She has explored many areas of interest and is being a part of the journalism industry.